Daniel F. Mandri

Daniel F. Mandri

Psychiatry | Internal Medicine
8785 SW 165th Ave
200
Miami, FL 33193

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1 publications

NBI-98854, a selective monoamine transport inhibitor for the treatment of tardive dyskinesia: A randomized, double-blind, placebo-controlled study.

NBI-98854, a selective monoamine transport inhibitor for the treatment of tardive dyskinesia: A randomized, double-blind, placebo-controlled study.

Journal: Movement disorders : official journal of the Movement Disorder Society
Published: March 04, 2015
Showing 1-1 of 1

Last Updated: 09/26/2026